Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19

While COVID-19, the disease driven by SARS-CoV-2 has ignited interest in the host immune response to this infection, it has also highlighted the lack of treatment options for the damaging inflammatory responses driven by pathogens that precipitate the acute respiratory distress syndrome (ARDS). With...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilroy, Derek W., De Maeyer, Roel P.H., Tepper, Mark, O’Brien, Alastair, Uddin, Mohib, Chen, Judy, Goldstein, Daniel R., Akbar, Arne N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657264/
https://www.ncbi.nlm.nih.gov/pubmed/33188794
http://dx.doi.org/10.1016/j.pharmthera.2020.107745

Ejemplares similares

Ejemplares similares